Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer
Authors
Keywords
-
Journal
Gastric Cancer
Volume 17, Issue 4, Pages 718-724
Publisher
Springer Nature
Online
2013-12-07
DOI
10.1007/s10120-013-0321-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort
- (2013) Simon Pernot et al. Gastric Cancer
- Docetaxel, Cisplatin and Fluorouracil (DCF) Regimen Compared with Non-Taxane-Containing Palliative Chemotherapy for Gastric Carcinoma: A Systematic Review and Meta-Analysis
- (2013) Xiao-Long Chen et al. PLoS One
- Current questions for the treatment of advanced gastric cancer
- (2012) A. Cervantes et al. CANCER TREATMENT REVIEWS
- A randomized phase II trial of S-1-oxaliplatin versus capecitabine–oxaliplatin in advanced gastric cancer
- (2012) Gun Min Kim et al. EUROPEAN JOURNAL OF CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Capecitabine in gastric cancer
- (2011) Yung-Jue Bang Expert Review of Anticancer Therapy
- Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis
- (2011) Francesco Montagnani et al. Gastric Cancer
- Docetaxel plus Oxaliplatin in Combination with Capecitabine as First-Line Treatment for Advanced Gastric Cancer
- (2011) K. Amarantidis et al. ONCOLOGY
- Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial
- (2010) N C Tebbutt et al. BRITISH JOURNAL OF CANCER
- Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer
- (2010) Michael J. Overman et al. CANCER
- Phase II Trial of XELOX as First-Line Treatment for Patients with Advanced Gastric Cancer
- (2010) Hui-yan Luo et al. CHEMOTHERAPY
- Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/III REAL-3 Trial
- (2010) Alicia F.C. Okines et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
- (2009) Y.-K. Kang et al. ANNALS OF ONCOLOGY
- Docetaxel: its role in current and future treatments for advanced gastric cancer
- (2009) Masahiko Nishiyama et al. Gastric Cancer
- Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma
- (2009) Luigi Di Lauro et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis
- (2009) Tetsuya Ueda et al. LANCET ONCOLOGY
- Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie
- (2008) S.-E. Al-Batran et al. ANNALS OF ONCOLOGY
- Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer
- (2008) K R Schønnemann et al. BRITISH JOURNAL OF CANCER
- Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
- (2008) Salah-Eddin Al-Batran et al. JOURNAL OF CLINICAL ONCOLOGY
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- (2008) David Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now